Literature DB >> 12773291

MR imaging of epilepsy: state of the art at 1.5 T and potential of 3 T.

Regula S Briellmann1, Gaby S Pell, R Mark Wellard, L Anne Mitchell, David F Abbott, Graeme D Jackson.   

Abstract

Shortly after being introduced in the nineteen eighties, magnetic resonance imaging (MRI) became a key tool for the investigation of patients with epilepsy, due to its ability to acquire high quality images. The strength of the magnetic field of a scanner is measured in tesla (T). This review addresses the clinical and research potential in epilepsy of MR imaging at 1.5 T and 3 T. A typical clinical scanning protocol at 1.5 T for a patient with refractory epilepsy may include T1- and T2-weighted imaging, fluid-attenuated inversion recovery (FLAIR) imaging, and a 3D volume acquisition sequence. A research protocol may add quantification of structural imaging, such as volumetric assessment and T2-relaxometry, together with functional measures, such as MR-spectroscopy, functional MRI and diffusion weighted sequences. MR-spectroscopy assesses the metabolites of the seizure focus and other brain areas. Functional MRI allows localisation of cognitive and sensori-motor function and the ability to assess the spatial relationship of these functions to the seizure focus. Whereas these techniques can be performed at 1.5 T, particularly MR-spectroscopy and functional MRI benefit from increased magnetic field-strength. Higher magnetic field-strength is associated with a higher signal-to-noise ratio (SNR). The increased SNR can allow shorter imaging times for a given resolution, higher resolution for a given imaging time, or combination of both. The use of higher magnetic field-strengths is therefore indicated for the (fast) imaging of ill subjects, for long protocols, including structural, metabolic and functional imaging, and for novel applications, such as continuous EEG recording and functional MRI for the detection of the seizure focus. Disadvantages of MR imaging in epilepsy at a high field-strength of 3 T and above are, apart from engineering and technical challenges, the greater energy deposition into tissue and increased susceptibility to artefacts. So far, magnets of 3 T and above have been used mainly for research applications, however the benefits of high field-strength for MR spectroscopy and functional MRI, and the usefulness of these techniques for the investigation of epilepsy patients are obvious incentives for the use of 3 T systems in routine clinical investigations.

Entities:  

Mesh:

Year:  2003        PMID: 12773291

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  7 in total

1.  MR imaging of the brachial plexus: comparison between 1.5-T and 3-T MR imaging: preliminary experience.

Authors:  Alberto Tagliafico; Giulia Succio; Carlo Emanuele Neumaier; Giovanni Serafini; Matteo Ghidara; Massimo Calabrese; Carlo Martinoli
Journal:  Skeletal Radiol       Date:  2010-10-23       Impact factor: 2.199

2.  3.0-T high-field magnetic resonance imaging of the female pelvis: preliminary experiences.

Authors:  N Morakkabati-Spitz; J Gieseke; C Kuhl; G Lutterbey; M von Falkenhausen; F Traeber; O Zivanovic; H H Schild
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 5.315

3.  Reliability of a new adjustable shunt device without the need for readjustment following 3-Tesla MRI.

Authors:  Wolf Lüdemann; Steffen K Rosahl; Jan Kaminsky; Madjid Samii
Journal:  Childs Nerv Syst       Date:  2005-01-19       Impact factor: 1.475

4.  Major depression in temporal lobe epilepsy with hippocampal sclerosis: clinical and imaging correlates.

Authors:  Regula S Briellmann; Malcolm J Hopwood; Graeme D Jackson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-26       Impact factor: 10.154

5.  Reproducibility of interictal EEG-fMRI results in patients with epilepsy.

Authors:  Taha Gholipour; Friederike Moeller; Francesca Pittau; François Dubeau; Jean Gotman
Journal:  Epilepsia       Date:  2010-11-03       Impact factor: 5.864

6.  Clinical development of experimental therapies for malignant glioma.

Authors:  Nikolai G Rainov; Volkmar Heidecke
Journal:  Sultan Qaboos Univ Med J       Date:  2011-02-12

7.  Optimizing the magnetization-prepared rapid gradient-echo (MP-RAGE) sequence.

Authors:  Jinghua Wang; Lili He; Hairong Zheng; Zhong-Lin Lu
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.